Skip to main content

Table 1 Demographic and clinical characteristics of the study’s participants (n = 124)

From: International Hip Outcome Tool (12-items) as health-related quality-of-life measure in osteoarthritis: validation of Greek version

Characteristics Valuesa
Age (years) 65.80 ± 8.25 (50–85)
Sex, n (%): men/women 29 (23%) / 95 (77%)
Height (m) 1.64 ± 0.08 (1.50–1.83)
Weight (kg) 76.14 ± 15.57 (48–135)
Body mass index (kg/m2) 28.07 ± 4.77 (17.4–45.6)
Dominant, n (%): right/left 104 (84%) / 20 (16%)
Affected hip, n (%): right/left 68 (55%) / 56 (45%)
Nocturnal pain, n (%): no/yes 61 (49%) / 63 (51%)
Morning stiffness, n (%): no/yes 48 (39%) / 76 (61%)
Assistive device, n (%): no/yes 100 (81%) / 24 (19%)
Kellgren–Lawrence classification of hip osteoarthritis,
n (%): Grade 1/2/3/4
5 (4.0%) / 18 (14%) / 64 (52%) / 37 (30%)
International hip outcome tool (12 items): Greek version’s total score (initial assessment) 38.17 ± 23.99 (3.3–95.8)
Lower extremity functional scale: Greek version’s total score 40.64 ± 17.84 (4.0–80.0)
Modified Harris hip score: Greek version’s total score 61.4 ± 18.76 (5.3–51.8)
30 s chair-to-stand test (rep) 8.00 ± 2.66 (2.0–18.0)
Timed Up and Go test performance time (s) 14.55 ± 7.86 (6.1–45.3)
9stairs-Ascent/Descent test performance time (s) 19.71 ± 9.56 (5.3–51.8)
  1. aThe values are expressed as Mean ± Standard deviation (SD) and Range for continuous variables and as frequencies (n) and percentages (%) for categorical variables